MedTrace Logo

Prospective Evaluation of Prognosis of Pci Patients Using Network Data in SHengjing Hospital

NCT02667548 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 7000

Last updated 2018-03-06

No results posted yet for this study

Summary

Coronary heart disease (CHD) has a serious health threaten to population. PCI is a well-proved measure in CHD management. However, the knowledge about the real-life PCI use and how evidence-based therapies in routine clinical practice is limited. By consecutively recruiting PCI patients in a large-scale hospital in in Northeast China,this study will examine various real-life factors, that may affect patients recovery after the procedure. Practical guidelines, appropriateness criteria and quality evaluative system for PCI will be established based on the findings, to improve patients outcomes in future finally.

Conditions

Interventions

PROCEDURE

PCI

percutaneous coronary intervention

Sponsors & Collaborators

  • Shengjing Hospital

    lead OTHER

Principal Investigators

  • Tongtong Yu, Doctor · Shengjing Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2021-01-31
Completion
2021-01-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02667548 on ClinicalTrials.gov